209 related articles for article (PubMed ID: 10700915)
1. Histopathological activity in paucibacillary leprosy patients after ROM therapy.
Ebenezer GJ; Job CK
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):409-13. PubMed ID: 10700915
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
3. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
[TBL] [Abstract][Full Text] [Related]
4. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
[TBL] [Abstract][Full Text] [Related]
5. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
Deshmukh AR; Dhurat RS; Jerajani HR
Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190
[TBL] [Abstract][Full Text] [Related]
6. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
2-3 Lesion Multicentre Trial Group
Indian J Lepr; 2001; 73(2):131-43. PubMed ID: 11579649
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
[TBL] [Abstract][Full Text] [Related]
8. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group.
Indian J Lepr; 1997; 69(2):121-9. PubMed ID: 9290963
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
[TBL] [Abstract][Full Text] [Related]
11. Histopathological lesions of apparently normal skin in leprosy patients.
Rashed HA; Mearag I; Saleh NM; Saied A
J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India.
Girdhar A; Kumar A; Girdhar BK
Lepr Rev; 2011 Mar; 82(1):46-54. PubMed ID: 21644471
[TBL] [Abstract][Full Text] [Related]
13. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
Emmanuel M; Gupte MD
Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic evidence to show that indeterminate leprosy may be a primary lesion of the disease.
Job CK; Baskaran B; Jayakumar J; Aschhoff M
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):443-9. PubMed ID: 9465152
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
Kumar A; Girdhar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
Manickam P; Nagaraju B; Selvaraj V; Balasubramanyam S; Mahalingam VN; Mehendale SM; Pannikar VK; Gupte MD;
Indian J Lepr; 2012; 84(3):195-207. PubMed ID: 23484334
[TBL] [Abstract][Full Text] [Related]
18. Single dose ROM therapy in Goa.
Shukla P; Miranda MS; Prabhudesai R; Rege VL
Indian J Lepr; 2002; 74(2):169-72. PubMed ID: 12708738
[No Abstract] [Full Text] [Related]
19. Persister studies in leprosy patients after multi-drug treatment.
Gupta UD; Katoch K; Singh HB; Natrajan M; Katoch VM
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
[TBL] [Abstract][Full Text] [Related]
20. Persistence of lepromatous granuloma in clinically cured cases of leprosy.
Desikan P; Desikan KV
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):417-21. PubMed ID: 7594925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
